Navigation Links
Bayer Diabetes Care Launches A1CNow(R) SELFCHECK, a New A1C Monitor for At-Home Use
Date:6/2/2009

Through Self A1C Testing, New Monitor Enables Diabetes Management Between Physician Visits

TARRYTOWN, N.Y., June 2 /PRNewswire/ -- Bayer Diabetes Care announced today the launch of A1CNow(R) SELFCHECK, a new A1C monitor that enables people with diabetes to check their A1C level at home. Measurement of A1C provides an average assessment of blood sugar levels over the past three months -- and is an indicator of how well diabetes is being managed. The U.S. Food and Drug Administration recently cleared Bayer's A1CNow SELFCHECK which enables patients to more closely watch their A1C level in between healthcare provider visits so they may modify their diet and exercise, or have a more informed discussion with their healthcare provider based on the results.

A1CNow SELFCHECK, which is now available without a prescription and through leading online pharmacies, provides at-home results within five minutes, has an easy-to-use design and delivers lab accuracy. Measuring A1C levels is important for consistent diabetes management, as even a one-percent reduction in A1C reduces the risk of serious complications by 40 percent(1).

"A1C testing is an important measure of long-term diabetes management, however, some patients will skip having their A1C tested because they're worried about what their healthcare provider will say if their A1C levels are not good," said Steve Edelman, MD, founder and director, Taking Control of Your Diabetes. "A1CNow SELFCHECK is a new tool that allows people with diabetes to test their A1C level in the comfort and privacy of their own home, to get the information they need to manage their disease in-between healthcare provider visits."

At the healthcare provider's office patients can be tested with Bayer's A1CNow+ monitor, which provides results within five minutes, enabling physicians to evaluate their patients' overall diabetes control and discuss lifestyle and treatme
'/>"/>

SOURCE Bayer Diabetes Care
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Non-Small Cell Lung Cancer
2. AUDIO from Medialink, Bayer Healthcare and Onyx Pharmaceuticals: Facts About Hepatitis
3. Bayer to Present Data on Development Compound BAY 73-4506 at 45th Annual Meeting of the American Society of Clinical Oncology
4. Now Available: Bayer Diabetes Cares CONTOUR(R) Meters in Midnight Blue and Orange Burst
5. Bayer CropScience Welcomes New Emergency Services Leader to the Institute Site
6. J&J, Schering-Plough, Novartis, Bayer vie for Top Honors at the Premier OTC / Healthcare Ad Awards
7. Bayer HealthCare Marks 20th Anniversary of World Hemophilia Day With Euro 250,000 Contribution to the World Federation of Hemophilia
8. Nick Jonas and Bayer Diabetes Care Launch Creativity Contest to Encourage Kids With Diabetes to Express Their Simple Win
9. Bayer Awards $200,000 to National Science Teachers Association to Nurture Early-Career Science Teachers
10. Bayer Consumer Care Joins Forces with WomenHeart to Fight Heart Disease
11. Podcast from Medialink, Bayer Healthcare LLC and WomenHeart: WomenHeart - Strong @Heart

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)..., Eating high amounts of salt is linked to a sign...r disease, states a paper published today in the ...ried out jointly by the World Health Organization,... University of Warwick and University Hospital in ...sion Excellence Centre in Hypertension based at th...
(Date:11/24/2009)... (Boston) Researchers from Boston University Scho...omedical Engineering Department have identified a ... distinguish between cancer and normal cells with ...searchers have developed a new computational strat... key biological pathways (molecular circuits) that...
(Date:11/24/2009)..., DALLAS,Nov.24/PRNewswire-USNewswire/--TheBa...erofoneofthelargestcancerclinicaltrialscooperative...theNationalCancerInstitute,SouthwestOncologyGroupc...ts,andtoimprovethequalityoflifeforcancersurvivors....feradditional,importantclinicaltrialstocancerpatie...
(Date:11/24/2009)..., LAKESUCCESS,N.Y.,Nov.24/PRNewswire-USNewswi...ation,aninternationalqualitymanagementstandardfocu...mersatisfactionandcontinuallyimprovingbusinessperf...nalCertificationServicesmeansIPRO,sQualityManageme...assingoperationsatitsofficesinLakeSuccessandAlbany...
(Date:11/24/2009)... The molecular cause of in...esearch will be presented at the upcoming 2009 Adv...quo;s & Colitis Foundation’s Clinical &a..., Florida, that may identify a causative mutation ... New York, NY (Vocus) November 24, 2009 -- The ...
Breaking Medicine News(10 mins):Health News:High salt intake linked to strokes and cardiovascular disease 2Health News:Researchers identify proteins in lung cancer cells that may provide potential drug targets 2Health News:Baylor Sammons Cancer Center Joins One of Nation's Largest Cancer Clinical Trials Groups 2Health News:IPRO Earns Third Consecutive Quality Management Certification 2Health News:Researchers Identify Possible Causative Mutation for Crohn's Disease: Crohn's & Colitis Foundation Annual Conference to Present Emerging Research 2Health News:Researchers Identify Possible Causative Mutation for Crohn's Disease: Crohn's & Colitis Foundation Annual Conference to Present Emerging Research 3Health News:Researchers Identify Possible Causative Mutation for Crohn's Disease: Crohn's & Colitis Foundation Annual Conference to Present Emerging Research 4
...COLUMBUS, Ohio, Nov. 2 GSW Worldwide, an inVentiv...rgest healthcare advertising,agencies in the world...,Diagnostics Company (BioBDx) for their McLean Mot...on Deficit,Hyperactivity Disorder (ADHD). GSW Wor...
...WILMINGTON, Del., Nov. 2 Staff and board,members ...ief Executive,Officer, Susan D. Lloyd, MSN, RN, fo...ion Dinner., Since 1987, Susan Lloyd has guided D... and compassion., In 1987, the five-year old Dela...
...WOODCLIFF LAKE, N.J., Nov. 2 Barr,Pharmaceuticals...idiary, Barr,Laboratories, Inc., has initiated a c...euticals Corporation in connection with its Ritali...containing a,paragraph IV certification for a gene...
...EmployeeElect will offer flexibility and cost-cont...rs in Maine,now have the health insurance options ...lue Shield announced today a new portfolio of elev...ce,choices than have ever been available for Maine...
...Data Expanded for Oncology, Neurology and Urology;... and OB/GYN, MOUNT LAUREL, N.J., Nov. 2 ImpactRx...ct of pharmaceutical promotion on,physicians, pres...ng client demand. ImpactRx is increasing the size ...
...WEST BRIDGEWATER, Mass., Nov. 2 Pressure,BioScien... that Richard T.,Schumacher, PBI Founder, Presiden...he Rodman & Renshaw Acumen BioFin 9th Annual Healt...ork,City. The Company,s audio portion and slides o...
Other Medicine News:Health News:GSW Worldwide Named Agency of Record for BioBehavioral Diagnostics Company's MMAT/ADHD(TM) System 2Health News:GSW Worldwide Named Agency of Record for BioBehavioral Diagnostics Company's MMAT/ADHD(TM) System 3Health News:Delaware Hospice Honors President and CEO Susan D. Lloyd, MSN, RN 2Health News:Delaware Hospice Honors President and CEO Susan D. Lloyd, MSN, RN 3Health News:Barr Confirms Patent Challenge of Ritalin(R) LA 2Health News:Barr Confirms Patent Challenge of Ritalin(R) LA 3Health News:Anthem Introduces New Insurance Options for Small Business 2Health News:ImpactRx Announces Expansion and Addition of Physician Information Networks 2Health News:ImpactRx Announces Expansion and Addition of Physician Information Networks 3Health News:Pressure BioSciences to Present at the Rodman & Renshaw BioFin 9th Annual Healthcare Conference in New York City on November 5th 2
(Date:11/24/2009)...if.,Nov.24/PRNewswire-FirstCall/--IPCTheHospitalis...talistphysiciangrouppracticecompany,announcedtoday...medby ACPHospitalist asoneofthe2009TopTenHospitali...ueofthemagazine. ,, Dr.Vaidyanhasbeenapracticin...rectorofhospitalmedicineatSt.Mary,sHealthCenterinS...
(Date:11/24/2009)...PRNewswire/--MAQUETCardiovascularLLC,aleadingprovi...ithassignedaguaranteedtwo-yearcontractwithNovation...ns,tobethesolesourceproviderofsurgicaldevicesforbe...agreement,whichrunsthroughOctober31,2012,MAQUETCar...tdevicesanddisposablesuppliestothemembersofVHAInc....
(Date:11/24/2009)....,Nov.24/PRNewswire/--SatelliteHealthcare,oneofthe...rvicesandamajorsponsorofnephrologyresearch,todayan...EliasNasrallahinhisefforttosupporttheSanJosehomele...ltasuccessfulcareerasachefforthepast20years.ButNas...ewasdiagnosedwithEndStageRenalDisease(ESRD).Thedia...
Breaking Medicine Technology:IPC The Hospitalist Company's Philip Vaidyan, M.D. Named a Top Hospitalist of 2009 2MAQUET Cardiovascular Receives Guaranteed Two-Year Sole Source Contract From Novation for Beating Heart Surgical Devices 2MAQUET Cardiovascular Receives Guaranteed Two-Year Sole Source Contract From Novation for Beating Heart Surgical Devices 3Satellite Healthcare and Renal Disease Survivor Elias Nasrallah Join Forces to Support the Homeless This Holiday Season 2Veran Medical Enables Breakthrough 4D Navigation to Cancer Lesions at University of Virginia Hospital 49893 1Veran Medical Enables Breakthrough 4D Navigation to Cancer Lesions at University of Virginia Hospital 49893 2Stay Upbeat Active to Keep the Mind Young 49889 1Stay Upbeat Active to Keep the Mind Young 49889 2Stay Upbeat Active to Keep the Mind Young 49889 310th CyberKnife System Installed at an HCA Hospital 49885 110th CyberKnife System Installed at an HCA Hospital 49885 210th CyberKnife System Installed at an HCA Hospital 49885 310th CyberKnife System Installed at an HCA Hospital 49885 4
...een across range of,patient populations, including...igh risk of developing diabetes , * Galvus lowers ...ing efficacy in combination with commonly used dia... in humans with studies showing,incidence of side ... * European regulatory decision anticipated by end...
...ents in Blood Glucose,Control and Progressive Weig...tCall/ -- Amylin,Pharmaceuticals, Inc. and Eli Lil...y that showed BYETTA(R) (exenatide) injection,sust...essive weight,loss through three and a half years ...ith improvements in cardiovascular risk,factors in...
Other Medicine Technology:New Data from Multiple Studies Show Galvus Delivers Consistent and,Robust Blood Sugar Control in Patients with Type 2 Diabetes 2New Data from Multiple Studies Show Galvus Delivers Consistent and,Robust Blood Sugar Control in Patients with Type 2 Diabetes 3New Data from Multiple Studies Show Galvus Delivers Consistent and,Robust Blood Sugar Control in Patients with Type 2 Diabetes 4New Data from Multiple Studies Show Galvus Delivers Consistent and,Robust Blood Sugar Control in Patients with Type 2 Diabetes 5New Data from Multiple Studies Show Galvus Delivers Consistent and,Robust Blood Sugar Control in Patients with Type 2 Diabetes 6Byetta Treatment for Three and a Half Years Associated with,Reductions in Cardiovascular Risk Factors in People with Type 2,Diabetes 2Byetta Treatment for Three and a Half Years Associated with,Reductions in Cardiovascular Risk Factors in People with Type 2,Diabetes 3Byetta Treatment for Three and a Half Years Associated with,Reductions in Cardiovascular Risk Factors in People with Type 2,Diabetes 4Byetta Treatment for Three and a Half Years Associated with,Reductions in Cardiovascular Risk Factors in People with Type 2,Diabetes 5Byetta Treatment for Three and a Half Years Associated with,Reductions in Cardiovascular Risk Factors in People with Type 2,Diabetes 6
...a pistol-grip handpiece available in Pneumatic, El...plers that can be used in a variety of orthopedic ...XT offers significantly increased torque and speed... Battery SmartDriver XT accepts the full line of S...
...ietary PolyGraft® material technology which pr...iologically friendly and biomechanically stable. ...calcium sulfate and polyglycolide fibers, the Poly...s such as granules, blocks, wedges and other prefo...
...resents the most widely accepted "table fixed" ret...ion components provides numerous surgical special... exposure of the surgical field.,Assembly is easy... before or during the procedure, thus saving valua...
Tipack (Sterilized) D1000
Medicine Products: